What is the official website of MSD Deutschland ?

The official website of MSD Deutschland is https://www.msd.de/impressum/.

What is MSD Deutschland's cybersecurity risk score?

MSD Deutschland has an AI-generated cybersecurity risk score of 761 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Deutschland experienced?

According to Rankiteo, MSD Deutschland currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Deutschland been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Deutschland has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Deutschland have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Deutschland is not certified under SOC 2 Type 1.

Does MSD Deutschland have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Deutschland does not hold a SOC 2 Type 2 certification.

Does MSD Deutschland comply with GDPR ?

According to Rankiteo, MSD Deutschland is not listed as GDPR compliant.

Does MSD Deutschland have PCI DSS certification ?

According to Rankiteo, MSD Deutschland does not currently maintain PCI DSS compliance.

Does MSD Deutschland comply with HIPAA ?

According to Rankiteo, MSD Deutschland is not compliant with HIPAA regulations.

Does MSD Deutschland have ISO 27001 certification ?

According to Rankiteo,MSD Deutschland is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Deutschland operate in ?

MSD Deutschland operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Deutschland have ?

MSD Deutschland employs approximately 1,982 people worldwide.

Does MSD Deutschland own any subsidiaries ?

MSD Deutschland presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Deutschland have ?

MSD Deutschland's official LinkedIn profile has approximately 44,605 followers.

What is the NAICS classification code for MSD Deutschland ?

MSD Deutschland is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does MSD Deutschland have a Crunchbase profile ?

No, MSD Deutschland does not have a profile on Crunchbase.

Does MSD Deutschland have a LinkedIn profile ?

Yes, MSD Deutschland maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-deutschland.

How many cybersecurity incidents has MSD Deutschland experienced ?

As of September 24, 2026, Rankiteo reports that MSD Deutschland has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Deutschland have ?

MSD Deutschland has an estimated 5,769 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Deutschland faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSD Deutschland

Boost Score +25 with badge (5 left)

761

/1000

Fair

786

/1000

Fair

MSD Deutschland Vendor Cyber Rating & Cyber Score

msd.de

Add Your Compliance Badge

Bei MSD, in den USA und Kanada bekannt als Merck & Co., Inc., Rahway, NJ, USA, eint uns ein Ziel: Wir nutzen führende wissenschaftliche Erkenntnisse, um auf der ganzen Welt Leben zu retten und mehr Lebensqualität zu ermöglichen. Bereits seit über 130 Jahren stehen wir durch die Entwicklung wichtiger neuer Medikamente und Impfstoffe für Fortschritt. Unser Anspruch ist es, als forschendes biopharmazeutisches Unternehmen global führend zu sein – und wir entwickeln innovative Gesundheitslösungen und Wirkstoffe, die die Prävention und Behandlung von Krankheiten bei Menschen und Tieren weiter verbessern. Wir fördern Vielfalt und Inklusion in unseren Teams weltweit und handeln jeden Tag verantwortungsbewusst, um allen Menschen eine sichere,

MSD Deutschland

MSD Deutschland CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Deutschland

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSD Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSD Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Deutschland in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Deutschland in 2026.

Incident Types MSD Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Deutschland in 2026.

Incident History - MSD Deutschland (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Deutschland Subsidiaries

MSD Deutschland

Pharmaceutical Manufacturing

Website: https://www.msd.de/impressum/

Company Size: 1,001-5,000 employees

MSDPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD EspañaPharmaceutical Manufacturing

MSD Animal HealthPharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD TürkiyePharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD JordanPharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD ÖsterreichPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD Deutschland Similar Companies

Lonza

lonza.com

Lonza is a pioneer and world leader in the CDMO industry, setting the pace with cutting-edge science, smart technology, and lean manufacturing. United by a common purpose, we turn our customers’ breakthrough innovations into viable therapies and manufacture the medicines of tomorrow. Founded in Switzerland in 1897, our company is the first and original CDMO, and today we are more dynamic, agile and forward-focused than ever before. As one of the largest Western CDMOs, we bring together a global team of around 18,500 colleagues across five continents to deliver comprehensive, integrated solutions for our customers' complex needs. For our customers and their patients, we bring quality, safety and reliability to bring life-enhancing and life-saving treatments to market at speed and at scale. For our colleagues, we strive to create a sense of belonging and inclusion where every person can thrive and bring their best.

Alkem Laboratories Ltd.

alkemlabs.com

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did! Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries 32% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged. We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries. Another feather in our cap was added on December 23rd, 2015, when, Alkem completed it's Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. Although passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 5 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Ipca Laboratories Limited

ipca.com

A consumer-led global pharmaceutical company, creating healthy doses of life since 1949. When you operate in an industry like pharmaceuticals, your work goes way beyond creating ‘products for customers’. It is different from any other domain – there lies a higher sense of responsibiliti and a need for utmost integriti in everything you do. As you serve millions of lives, high qualiti standards become a pre-requisite, and safeti of your people and consumers always comes first. All this, while ensuring that each life you touch is treated with respect and digniti. For more than 60 years, Ipca has been a crucial healthcare partner in over 120 countries across the 6 continents. We are a fully-integrated pharmaceutical company that manufactures over 350 formulations and 80 APIs for various therapeutic segments. Today, we are one of the world’s largest manufacturers and suppliers of over a dozen APIs. These are produced from scratch at fully-automated manufacturing facilities, approved by the world’s most discerning drug regulatory authorities like UK-MHRA, EDQM-Europe, and WHO-Geneva, among others. - One of the largest suppliers of these APIs worldwide with manufacturing leadership in over 12 APIs globally - 15 APIs & 11 Formulations manufacturing facility across the globe Leader in DMARDs (Disease Modifying Anti-Rheumatic Drugs) treatment for Rheumatoid Arthritis - Leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy - 4 formulations rank amongst the top 300 brands of IPM as per IQVIA

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

Merck

merck.us

At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com. This site is intended for residents of the United States and Canada and their territories only. FLS: http://merck.us/3TKXNuZ

Bristol Myers Squibb

cb bms.com

At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, a career at BMS means you’ll be inspired every day to grow and thrive through opportunities that are uncommon in scale and scope. Here, you’ll be on the cutting edge of powerful innovation in oncology, hematology, immunology, cardiovascular disease, and fibrosis, with colleagues united in the mission to help patients. Through the Bristol Myers Squibb Foundation, we also promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions. Our mission is to give new hope to help patients prevail over serious disease – it drives everything we do. Review our Social Media Community Guidelines at: https://www.bms.com/social-media-community-guidelines.html

Loading…

NEWS

MSD Deutschland CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

October 26, 2023 04:30 PM

AI-Powered CRM and ERP Solutions | Microsoft Dynamics 365

Enter the era of AI-powered business with Dynamics 365—CRM and ERP business applications that connect your teams, processes, and data.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96680

SUMMARY

A vulnerability was detected in ByteDance Coze Scraper Extension up to 2.0.2. Affected by this vulnerability is the function chrome.runtime.onMessageExternal.addListener of the file static/background/index.js of the component External Message Handler. The manipulation of the argument body.url/paginationConfig/xPathConfig/body.urls/xPaths results in missing authorization. The attack can be launched remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-96678

SUMMARY

A security vulnerability has been detected in weiqingwen spring-boot-forum up to 538eecc3c6b85fdf0768ab4e8354b48c0c17d94f. Affected is the function validate of the file src/main/java/com/qingwenwei/util/NewUserFormValidator.java of the component Avatar Upload. The manipulation of the argument Username leads to path traversal. The attack can be initiated remotely. The exploit has been disclosed publicly and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96676

SUMMARY

A vulnerability was identified in Fast FAC1900R 20190827_2.0.2. The impacted element is the function get_alias_name of the component uhttpd. Such manipulation leads to stack-based buffer overflow. The attack may be performed from remote. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

CVE-2026-96606

SUMMARY

A security flaw has been discovered in LB-Link BL-CPE600EU 5.8.13. This vulnerability affects unknown code of the file Mifi_config.bin of the component Configuration Backup Handler. The manipulation results in information disclosure. The attack can be launched remotely. The exploit has been released to the public and may be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 5.0

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:N/A:N

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

3.9

REFERENCES

CVE-2026-70125

SUMMARY

Microsoft Outlook Remote Code Execution Vulnerability

Published

Date2026-09-23

Updated

Date2026-09-23

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://msrc.microsoft.com/update-guide/vulnerability/CVE-2026-70125

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

MSD Deutschland Vendor Cyber Rating & Cyber Score

MSD Deutschland A.I CyberSecurity Scoring

MSD Deutschland CyberSecurity News & History

MSD Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSD Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSD Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSD Deutschland (X = Date, Y = Severity)

MSD Deutschland Subsidiaries

MSD Deutschland

MSD Deutschland Similar Companies

Lonza

Alkem Laboratories Ltd.

MANKIND PHARMA LTD

MACLEODS PHARMACEUTICALS LTD.

Ipca Laboratories Limited

PT Kalbe Farma, Tbk

Teva Pharmaceuticals

Merck

Bristol Myers Squibb

MSD Deutschland CyberSecurity News

AI-Powered CRM and ERP Solutions | Microsoft Dynamics 365

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

MSD Deutschland CyberSecurity News & History

MSD Deutschland Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for MSD Deutschland

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types MSD Deutschland vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - MSD Deutschland (X = Date, Y = Severity)

MSD Deutschland Subsidiaries

MSD Deutschland

MSD Deutschland Similar Companies

Lonza

Alkem Laboratories Ltd.

MANKIND PHARMA LTD

MACLEODS PHARMACEUTICALS LTD.

Ipca Laboratories Limited

PT Kalbe Farma, Tbk

Teva Pharmaceuticals

Merck

Bristol Myers Squibb

MSD Deutschland CyberSecurity News

AI-Powered CRM and ERP Solutions | Microsoft Dynamics 365

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo